Alpha Tau Medical Ltd.
DRTSDrugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Frequently asked questions
What is in Alpha Tau Medical Ltd.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Alpha Tau Medical Ltd.'s (DRTS) pipeline across Phase 3, Phase 2. Its lead program is AZD3759 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Alpha Tau Medical Ltd.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Alpha Tau Medical Ltd. (DRTS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track DRTS biotech catalysts?→
Add DRTS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Alpha Tau Medical Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.